Curiosis KRX:494120KOSDAQ
큐리오시스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked13since Sep 11
In Q2 2026, Curiosis reported revenue of ₩3.5bn, up 72.9% year on year, and an operating loss of ₩1.9bn. Curiosis (큐리오시스) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 22 with 8 articles. It was most often mentioned alongside 글로벌테크놀로지.
Filing signals 4 quarters of losses Screener
Curiosis quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩3.5bn | +72.9% | −₩1.9bn margin −53.8% | −₩2.1bn |
| Q1 2026 | ₩1.1bn | -25.5% | −₩1.6bn margin −140.2% | −₩1.5bn |
| Q4 2025 derived | ₩2.7bn | +66.8% | −₩2.3bn margin −85.4% | −₩2.3bn |
| Q3 2025 | ₩1.2bn | -25.3% | −₩2.1bn margin −180.7% | −₩2.1bn |
| Q2 2025 | ₩2.0bn | +53.5% | −₩1.3bn margin −65.8% | −₩1.3bn |
| Q1 2025 | ₩1.5bn | +60.5% | −₩1.8bn margin −119.3% | −₩2.2bn |
| Q4 2024 derived | ₩1.6bn | – | −₩2.3bn margin −141.9% | −₩639m |
| Q3 2024 | ₩1.5bn | – | −₩1.1bn margin −74.6% | −₩1.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Curiosis top stories 2 weeks, by number of outlets
- 1
- 2
- 3
Latest Curiosis news Korean headlines
-
큐리오시스, 세계 바이오 서밋서 AI 기반 자율실험실 비전 제시
5 more on this story · 5 outlets
- 큐리오시스 윤호영 대표, 세계 바이오 서밋서 자율실험실 비전 제시메디포뉴스 · Oct 22 08:47
- 큐리오시스, 세계 바이오 서밋서 자율실험실 비전 제시뉴스핌 · Oct 22 09:19
- 큐리오시스, 세계 바이오 서밋서 AI 자율실험실 기술 공개뉴스1 · Oct 22 09:28
- 큐리오시스 "세계 바이오 서밋서 자율실험실(SDL) 비전 제시"히트뉴스 · Oct 22 10:12
- 큐리오시스, 세계 바이오 서밋서 AI 자율실험실 기술 소개메디파나뉴스 · Oct 22 12:11
-
큐리오시스-AI신약연구원, 자율실험실 인재 양성 맞손
1 more on this story · 1 outlets
- 큐리오시스, AI신약연구원과 맞손…자율실험실 인재 양성이데일리 · Sep 15 10:38